Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.90 EUR
290.40 M EUR
2.09 B EUR
36.55 M
About CARL ZEISS MEDITEC AG
Sector
Industry
CEO
Markus Weber
Website
Headquarters
Jena
Founded
1995
ISIN
DE0005313704
FIGI
BBG000C7X5F6
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. It operates through the Ophthalmic Strategic Business Unit (SBU) and Microsurgery business SBU segments. The Ophthalmic SBU segment includes intraocular lenses, surgical visualization solutions, and medical laser and diagnostic systems. The Microsurgery SBU segment offers surgical microscopes and visualization solutions for neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiotherapy. The company was founded in 2002 and is headquartered in Jena, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AFX is 55.70 EUR — it has increased by 0.71% in the past 24 hours. Watch CARL ZEISS MEDITEC AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange CARL ZEISS MEDITEC AG stocks are traded under the ticker AFX.
AFX stock has fallen by −0.44% compared to the previous week, the month change is a −1.64% fall, over the last year CARL ZEISS MEDITEC AG has showed a −33.75% decrease.
We've gathered analysts' opinions on CARL ZEISS MEDITEC AG future price: according to them, AFX price has a max estimate of 104.00 EUR and a min estimate of 45.00 EUR. Watch AFX chart and read a more detailed CARL ZEISS MEDITEC AG stock forecast: see what analysts think of CARL ZEISS MEDITEC AG and suggest that you do with its stocks.
AFX stock is 3.92% volatile and has beta coefficient of 1.22. Track CARL ZEISS MEDITEC AG stock price on the chart and check out the list of the most volatile stocks — is CARL ZEISS MEDITEC AG there?
Today CARL ZEISS MEDITEC AG has the market capitalization of 5.09 B, it has decreased by −6.58% over the last week.
Yes, you can track CARL ZEISS MEDITEC AG financials in yearly and quarterly reports right on TradingView.
CARL ZEISS MEDITEC AG is going to release the next earnings report on Dec 11, 2024. Keep track of upcoming events with our Earnings Calendar.
AFX net income for the last half-year is 83.87 M EUR, while the previous report showed 177.35 M EUR of net income which accounts for −52.71% change. Track more CARL ZEISS MEDITEC AG financial stats to get the full picture.
Yes, AFX dividends are paid annually. The last dividend per share was 1.10 EUR. As of today, Dividend Yield (TTM)% is 1.93%. Tracking CARL ZEISS MEDITEC AG dividends might help you take more informed decisions.
CARL ZEISS MEDITEC AG dividend yield was 1.33% in 2023, and payout ratio reached 33.88%. The year before the numbers were 1.02% and 33.47% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 3, 2024, the company has 4.82 K employees. See our rating of the largest employees — is CARL ZEISS MEDITEC AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CARL ZEISS MEDITEC AG EBITDA is 373.98 M EUR, and current EBITDA margin is 20.92%. See more stats in CARL ZEISS MEDITEC AG financial statements.
Like other stocks, AFX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CARL ZEISS MEDITEC AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CARL ZEISS MEDITEC AG technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CARL ZEISS MEDITEC AG stock shows the sell signal. See more of CARL ZEISS MEDITEC AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.